Cutler Group LP Brooklyn Immuno Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 04, 2022	SELL	$0.48 - $2.03 $720 - $3,044	-1,500 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$1.76 - $4.84 $1,584 - $4,356	900 Added 150.0%	1,500 $16,000
Q4 2021 Jan 18, 2022	SELL	$4.17 - $9.79 $27,105 - $63,634	-6,500 Reduced 91.55%	600 $3,000
Q3 2021 Oct 26, 2021	SELL	$8.86 - $17.05 $886 - $1,705	-100 Reduced 1.39%	7,100 $24,000
Q2 2021 Jul 19, 2021	BUY	$3.75 - $78.5 $27,000 - $565,200	7,200 New	7,200 $10,000

1.21M

Ticker BTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,825,700
Description
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.